Latest News about Alzheimer's disease
Recent news which mentions Alzheimer's disease
From CNBC.com News
From CNBC.com News
Biogen isn't concerned about competing with Eli Lilly in the Alzheimer’s drug space, CEO says
April 25, 2023
From CNBC.com News
March 2023 Miscellany
March 27, 2023
From Stock Gumshoe
Getting Back to You on Anavex, Cassava, metformin and more
January 17, 2023
From Stock Gumshoe
Relevant Updates – December 2022
December 27, 2022
From Stock Gumshoe
Roche's Another Alzheimer's Hopeful Flops In Phase 3 Program, Second Trial Setback Within Months
November 14, 2022
From Benzinga
A brain expert shares his 7 'hard rules' for boosting memory and fighting off dementia
November 13, 2022
From CNBC.com News
Odd & Ends – October 2022
October 27, 2022
From Stock Gumshoe
These Stocks Are On The Radar After Biogen-Eisai's Surprising Alzheimer's Trial Win
September 28, 2022
From Benzinga
Alzheimer's Progression Slowed Down By Biogen's New Drug In Late-Stage Study: Analyst Sees 25% Upside For Stock
September 28, 2022
From Benzinga
Following Up on Your Suggestions – September 2022
September 26, 2022
Tickers
DIET
From Stock Gumshoe
Tickers
DGX
From Stock Gumshoe
From Benzinga
From Stock Gumshoe
Researchers Investigate New Treatment Pathways For Alzheimer's After Commercial Failure Of Biogen's Aduhelm
May 23, 2022
Tickers
BIIB
From Benzinga
From Stock Gumshoe
From Benzinga
New York Times Report Fresh Allegations On Cassava's Simufilam Alzheimer's Trials, Shares Fall
April 19, 2022
Tickers
SAVA
From Benzinga
EXCLUSIVE: Longeveron Adds Miami Veterans Affairs Site To Its Ongoing Mid-Stage Alzheimer's Trial
April 13, 2022
Tickers
LGVN
From Benzinga
Biogen's Alzheimer's Drug Aduhelm Medicare Coverage Restricted To Just Clinical Trials, CMS Finalizes
April 08, 2022
Tickers
BIIB
From Benzinga
EXCLUSIVE: Longeveron's Lomecel-B Data In Alzheimer's Disease Published In Medical Journal
March 31, 2022
Tickers
LGVN
From Benzinga
From Benzinga
Prothena Highlinghts New Preclinical Data For Alzheimer's, Parkinson's Vaccine Programs
March 16, 2022
Tickers
PRTA
From Benzinga
Gain Therapeutics Posts Encouraging Preclinical Data From Parkinson's, Alzheimer's Programs
March 15, 2022
Tickers
GANX
From Benzinga
Biogen, Eisai Amend Their Alzheimer's Drug Marketing Pact
March 15, 2022
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Free News Feed
Get our RSS Feed!
© Copyright 2008 StreetInsider.com
Custom Website Design by Active Media Architects
Custom Website Design by Active Media Architects
